1. Home
  2. OLMA vs NAN Comparison

OLMA vs NAN Comparison

Compare OLMA & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NAN
  • Stock Information
  • Founded
  • OLMA 2006
  • NAN 1999
  • Country
  • OLMA United States
  • NAN United States
  • Employees
  • OLMA N/A
  • NAN N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NAN Investment Managers
  • Sector
  • OLMA Health Care
  • NAN Finance
  • Exchange
  • OLMA Nasdaq
  • NAN Nasdaq
  • Market Cap
  • OLMA 378.9M
  • NAN 337.8M
  • IPO Year
  • OLMA 2020
  • NAN N/A
  • Fundamental
  • Price
  • OLMA $7.89
  • NAN $11.51
  • Analyst Decision
  • OLMA Strong Buy
  • NAN
  • Analyst Count
  • OLMA 5
  • NAN 0
  • Target Price
  • OLMA $24.00
  • NAN N/A
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • NAN 74.6K
  • Earning Date
  • OLMA 11-11-2025
  • NAN 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • NAN 4.37%
  • EPS Growth
  • OLMA N/A
  • NAN N/A
  • EPS
  • OLMA N/A
  • NAN N/A
  • Revenue
  • OLMA N/A
  • NAN N/A
  • Revenue This Year
  • OLMA N/A
  • NAN N/A
  • Revenue Next Year
  • OLMA N/A
  • NAN N/A
  • P/E Ratio
  • OLMA N/A
  • NAN N/A
  • Revenue Growth
  • OLMA N/A
  • NAN N/A
  • 52 Week Low
  • OLMA $2.86
  • NAN $9.11
  • 52 Week High
  • OLMA $13.93
  • NAN $11.34
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.97
  • NAN 75.56
  • Support Level
  • OLMA $7.49
  • NAN $10.90
  • Resistance Level
  • OLMA $8.25
  • NAN $11.60
  • Average True Range (ATR)
  • OLMA 0.66
  • NAN 0.06
  • MACD
  • OLMA 0.12
  • NAN 0.07
  • Stochastic Oscillator
  • OLMA 80.06
  • NAN 87.14

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: